Not finding it? Sign in to also search OpenAlex live.
-
Feasibility and safety of transcranial direct current stimulation in the treatment of adolescent depression in a naturalistic inpatient setting: a double-blind randomized controlled trial
Franziska Martin, Hannah Brauer, Alexander Prehn‐Kristensen, Julia Siemann, Martin Holtmann, Tanja Legenbauer, +1 more
0citations -
Safety, reactogenicity, and immunogenicity of different doses of 10-valent Extraintestinal Pathogenic Escherichia Coli (ExPEC10V) bioconjugate vaccine (VAC52416) in healthy Japanese adults aged 60–85 years in a randomized, double-blind, phase 1 study2024 Journal of Infection and Chemotherapy article Biochemistry, Genetics and Molecular Biology Escherichia coli research studies Open access
Miwa Haranaka, Atsushi Momose, Yoshikazu Nakayama, Yuki Saito, Bart Spiessens, Todd A. Davies, +3 more
0citations -
Adding eltrombopag to immunosuppressive treatment with cyclosporine as front-line therapy for moderate aplastic anemia improves trilineage hematologic response: One-year analysis of the randomised, placebo-controlled, double-blind Phase III trial eltrombopag for moderate aplastic anemia (EMAA Trial)
Britta Hoechsmann, Philippe Schafhausen, Fabian Beier, Michael Heuser, Joerg Westermann, Beatrice Drexler, +10 more
0citations -
Pilocarpine Drops for Xerostomia in Patients With a Life-Limiting Condition or Frailty: A Double-Blind Placebo-Controlled Randomized Clinical Trial2026 Journal of the American Medical Directors Association article Medicine Salivary Gland Disorders and Functions Open access
Annelot I. van der Meulen, Judith L. Gulikers, Maurice Theunissen, Sander M. J. van Kuijk, Merel Kimman, Bénédicte J. E. G. Coenegracht, +3 more
0citations -
Hydrocortisone or Placebo to Reduce Dexamethasone-Induced Neurobehavioral Side Effects: Results of a Phase 3 National, Double-Blind, Placebo-Controlled Randomized Trial with Crossover Design
Annelienke M. van Hulst, Erica L T van den Akker, Emma J. Verwaaijen, Marta F. Fiocco, Niki Rensen, Raphaële R. L. van Litsenburg, +7 more
0citations -
A randomized, double-blind, placebo-controlled, mechanistic trial on the safety, tolerability and pharmacodynamics of ninerafaxstat in patients with angina and chronic coronary syndrome
Juhani M. Knuuti, Roni Ranghoej Nielsen, Jerome J. Bax, Lars Christian Gormsen, Frank Arnold Flachskampf, Christina Jespersen, +8 more
0citations -
Electric Pulp Testing Evaluation of Dental Anesthesia After 660-nm Laser-Photoiomodulation Therapy: Results of a Double-Blind Randomized, Placebo-Controlled Clinical Trial0citations
-
The importance of hair in human perception of electric fields – A double-blind repeated measures study2026 Scientific Reports article Biochemistry, Genetics and Molecular Biology Electromagnetic Fields and Biological Effects Open access
Kathrin Jankowiak, Andrea Kaifie, Julia Krabbe, Maike Franziska Dohrn, Simon Kimpeler, Frederik Mingers, +2 more
0citations -
MON-314 Analysis of Adverse Events in Adult Patients with Acromegaly Receiving Oral Octreotide Capsules: Results from the Phase 3, Randomized, Double-Blind, Placebo-Controlled CHIASMA OPTIMAL Study2020 Journal of the Endocrine Society article Medicine Pituitary Gland Disorders and Treatments Open access
Artak Labadzhyan, Susan Leanne Samson, Lisa B. Nachtigall, Maria Fleseriu, William Henry Ludlam, H Patou, +7 more
0citations -
MON-LB55 Biochemical Control of Most Patients Reverting to Injectable Long-Acting Somatostatin Receptor Ligands Is Achieved After One Dose: Results From the Phase 3, Randomized, Double Blind, Placebo-Controlled Optimal Study2020 Journal of the Endocrine Society article Medicine Pituitary Gland Disorders and Treatments Open access
Maria Fleseriu, Susan Leanne Samson, Lisa B. Nachtigall, Artak Labadzhyan, Atanaska P. Elenkova, William Henry Ludlam, +6 more
0citations -
Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial2020 The Lancet article Medicine Spondyloarthritis Studies and Treatments Open access cited by 2 patents
Philip J. Mease, Proton Rahman, Alice Bendix Gottlieb, Alexa P. Kollmeier, Elizabeth C. Hsia, Xie Lillian Xu, +5 more
359citations -
Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial
Doortje I Krijbolder, Marloes Verstappen, Bastiaan T van Dijk, Yousra J. Dakkak, Leonie E. Burgers, Aleid C. Boer, +10 more
183citations -
Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial2022 The Lancet Respiratory Medicine article Medicine COVID-19 Clinical Research Studies Open access cited by 2 patents
Alexander P. J. Vlaar, Martin Witzenrath, Pieter van Paassen, Leo M. A. Heunks, Bruno Mourvillier, Sanne de Bruin, +71 more
154citations -
Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial
Atul A. Deodhar, Filip E Van den Bosch, Denis Poddubnyy, Walter P. Maksymowych, Désirée M F M van der Heijde, Tae‐Hwan Kim, +7 more
142citations -
Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial2024 The Lancet Neurology article Biochemistry, Genetics and Molecular Biology Muscle Physiology and Disorders Open access cited by 1 patent
Eugenio Maria Mercuri, Juan Jesus Vilchez, Odile Boespflug‐Tanguy, Craig Mitchell Zaidman, Jean Kit-Wah Mah, Nathalie Goemans, +51 more
136citations -
Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial
Christa Walgaard, Bart C. Jacobs, Hester Floor Lingsma, Ewout Willem Steyerberg, Bianca van den Berg, Alexandra Y. Doets, +48 more
121citations -
Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 ( DNL747 ) for neurodegenerative disorders: Randomized, placebo‐controlled , double‐blind phase I/Ib studies in healthy subjects and patients2022 Clinical and Translational Science article Medicine Alzheimer's disease research and treatments Open access cited by 1 patent
Maurits F. J. M. Vissers, Jules A. A. C. Heuberger, Geert Jan Groeneveld, Jerome Oude Nijhuis, Peter Paul De Deyn, Salah Hadi, +17 more
112citations -
Safety and efficacy of pitolisant in children aged 6 years or older with narcolepsy with or without cataplexy: a double-blind, randomised, placebo-controlled trial
Yves A Dauvilliers, Michel Lecendreux, Gert Jan Lammers, Patricia Franco, Mikhail Gur'evich Poluektov, Christian Caussé, +2 more
112citations